The relative risk (risk ratio) compares incidence between exposed and unexposed groups, conveying how much more likely exposure makes an outcome. The odds ratio approximates the risk ratio for rare diseases and is the native output of logistic regression. Attributable risk (risk difference) quantifies the absolute excess burden due to exposure, which matters more for policy prioritization than relative measures alone. Population attributable fraction estimates how much disease would be eliminated if an exposure were removed from the population entirely, combining the size of the exposed group with the strength of association.
Practice computing RR, OR, AR, and PAF from 2×2 contingency tables. Then interpret a set of real epidemiologic findings where RR and AR tell conflicting 'importance' stories—this crystallizes why both perspectives are necessary.
When you studied disease frequency measures, you learned to quantify how common a condition is using incidence rates and prevalence. Measures of association take the next step: comparing those frequencies between groups to determine whether an exposure is linked to an outcome, and how strongly.
The relative risk (RR), also called the risk ratio, is the most direct measure. Divide the incidence rate in the exposed group by the incidence rate in the unexposed group. An RR of 4 means exposed individuals develop the outcome four times as often. An RR of 1 means no difference. The RR is most naturally computed from cohort studies, where you follow exposed and unexposed groups forward in time and compare outcomes.
The odds ratio (OR) answers a similar question but is calculated differently — as the ratio of the odds of disease in the exposed group to the odds in the unexposed group. The OR is the native measure in case-control studies and logistic regression, because those designs do not yield incidence rates directly. When the disease is rare (roughly under 10% prevalence), the OR closely approximates the RR. For common outcomes, the OR exaggerates the association and should not be interpreted as though it were an RR.
Both RR and OR tell you about *relative* differences between groups, but they say nothing about absolute burden. This is where attributable risk (AR) enters. The risk difference — incidence in exposed minus incidence in unexposed — tells you how much extra disease the exposure adds per person at risk. An exposure might have an RR of 10, but if baseline incidence is 1 in a million, the AR is only 9 in a million — still extremely rare. Conversely, a modest RR applied to a very common exposure can produce a large AR.
Finally, the population attributable fraction (PAF) asks: if this exposure were entirely eliminated from the population, what fraction of all cases would disappear? PAF incorporates both the strength of the association and the prevalence of the exposure. A moderate association with a very common exposure can have a higher PAF than a dramatic association with a rare one. This is why addressing ubiquitous risk factors like physical inactivity or high dietary sodium often prevents more total disease than addressing rarer but biologically potent exposures. Knowing when to emphasize relative versus absolute versus population-level measures is the core practical skill this topic develops.